Position in HLN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$727
-$53 QoQ
Shares Held
78
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#609
of 639 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Elevated Capital Advisors, LLC holds $5,043 across 4 Drug Manufacturers - Specialty & Generic names. HLN ranks #3 (14.4% of the industry book) .
All Filings in HLN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $727 | 78 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $780 | 78 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $788 | 78 | Shares | Sole | 2026-01-27 | |
| No filing history on record for this holder in this stock. | ||||||